V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003188 | 300005883 | null | null | Adjuvant (A) | 2016-02-09 | 2016-03-01 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 300014795 | GEMCITABINE |
| 300003189 | 300002221 | 1.9 | 105 | Palliative (P) | 2015-08-01 | 2015-08-09 | Gemcitabine weekly | N | N | 300014796 | GEMCITABINE |
| 300003190 | 300002222 | 1.77 | null | Adjuvant (A) | 2015-08-18 | 2015-09-09 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 300014797 | GEMCITABINE |
| 300003191 | 300002223 | 1.57 | 66.2 | Curative (C) | null | 2016-08-30 | Cisplatin | N | Y | 300014798 | CISPLATIN |
| 300003192 | 300002224 | 1.67 | null | Curative (C) | 2015-03-24 | 2015-04-23 | Cisplatin | N | N | 300014799 | CISPLATIN |
| 300003193 | 300002225 | 1.79 | 72.8 | Adjuvant (A) | null | 2013-06-03 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 300014801 | GEMCITABINE |
| 300003194 | 300002226 | 1.62 | 75.15 | Adjuvant (A) | 2016-11-26 | 2016-12-01 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 300014805 | GEMCITABINE |
| 300003195 | 300002227 | 1.63 | 63.8 | null | 2015-02-09 | 2015-02-17 | Cisplatin | N | N | 300014806 | CISPLATIN |
| 300003196 | 300002228 | 1.56 | 61.7 | Adjuvant (A) | null | 2014-06-17 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 300014811 | GEMCITABINE |
| 300003197 | 300002229 | 1.75 | 79.7 | null | 2015-04-17 | 2015-04-24 | GEMCITABINE | N | N | 300014818 | GEMCITABINE |
| 300003198 | 300002230 | null | null | Curative (C) | 2016-01-08 | 2016-02-09 | Cisplatin 7 day | 02 | Y | 300014822 | CISPLATIN |
| 300003200 | 300005884 | 1.87 | 110.4 | Palliative (P) | 2015-11-18 | 2015-11-30 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 300014832 | GEMCITABINE |
| 300003201 | 300005884 | 1.8 | 72.3 | Curative (C) | 2014-11-25 | 2014-11-25 | Trial Unspecified | N | N | 300014832 | TRIAL |
| 300003202 | 300002232 | 1.73 | 66.35 | Curative (C) | 2016-12-30 | 2017-01-09 | Cetuximab + Radiotherapy Load | 02 | null | 300014839 | CETUXIMAB + RT |
| 300003203 | 300002233 | 1.47 | 104.4 | Adjuvant (A) | 2016-09-21 | 2016-10-09 | Capecitabine | Y | N | 300014842 | CAPECITABINE |
| 300003204 | 300002234 | 1.74 | 73.8 | Palliative (P) | 2015-02-20 | 2015-02-21 | CISPLATIN + FLUOROURACIL | 02 | null | 300014844 | CISPLATIN + FLUOROURACIL |
| 300003205 | 300002235 | 1.75 | 61.2 | Curative (C) | 2014-11-13 | 2014-12-05 | Capecitabine | N | N | 300014845 | CAPECITABINE |
| 300003209 | 300002237 | 1.73 | 90.95 | Curative (C) | 2015-08-13 | 2015-08-16 | Capecitabine | 02 | N | 300014857 | CAPECITABINE |
| 300003210 | 300002238 | null | 104.1 | Curative (C) | 2016-05-01 | 2016-05-22 | CETUXIMAB | 02 | N | 300014859 | CETUXIMAB |
| 300003211 | 300002238 | 1.72 | 67 | Adjuvant (A) | 2018-04-23 | 2018-05-06 | Capecitabine | N | N | 300014859 | CAPECITABINE |
| 300003212 | 300002239 | 1.69 | 57.8 | Curative (C) | null | 2016-09-27 | Cetuximab + Radiotherapy Load | N | Y | 300014868 | CETUXIMAB + RT |
| 300003213 | 300002240 | 1.54 | 40 | Palliative (P) | 2014-10-17 | 2014-10-23 | Cetuximab 7 day (Cycle 1) | 02 | N | 300014870 | CETUXIMAB |
| 300003214 | 300002241 | 1.81 | null | null | null | 2016-11-23 | Capecitabine | N | N | 300014871 | CAPECITABINE |
| 300003215 | 300002242 | 1.64 | 88 | Curative (C) | 2015-12-06 | 2015-12-25 | Capecitabine | 02 | N | 300014872 | CAPECITABINE |
| 300003216 | 300005887 | 1.69 | null | Neo-adjuvant (N) | 2015-07-09 | 2015-07-09 | Cisplatin +Fluorouracil (2 wk) | 01 | N | 300014875 | CISPLATIN + FLUOROURACIL |
| 300003217 | 300005887 | 1.58 | 74.9 | Adjuvant (A) | 2016-06-22 | 2016-06-23 | Capecitabine | 02 | N | 300014875 | CAPECITABINE |
| 300003218 | 300002243 | null | 88.5 | Neo-adjuvant (N) | 2014-03-05 | 2014-03-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300014880 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003220 | 300002245 | 1.66 | 81.4 | Palliative (P) | 2015-09-20 | 2015-09-23 | Trial Unspecified | 02 | Y | 300014888 | TRIAL |
| 300003221 | 300002245 | 1.53 | 58.95 | Curative (C) | 2016-05-21 | 2016-06-10 | CETUXIMAB + RT | N | Y | 300014888 | CETUXIMAB + RT |
| 300003223 | 300002247 | 1.59 | 68.6 | Not known (9) | 2014-04-07 | 2014-04-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300014892 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003224 | 300002248 | 1.63 | 75 | Curative (C) | 2014-05-22 | 2014-05-22 | CETUXIMAB | 2 | N | 300014897 | CETUXIMAB |
| 300003225 | 300002249 | 1.58 | 90.7 | null | null | 2018-01-19 | CISPLATIN + FLUOROURACIL | null | null | 300014899 | CISPLATIN + FLUOROURACIL |
| 300003226 | 300002250 | 1.5 | 92 | Not known (9) | 2015-02-22 | 2015-03-09 | CARBOPLATIN + PACLITAXEL | N | N | 300014907 | CARBOPLATIN + PACLITAXEL |
| 300003227 | 300002251 | 1.67 | 70 | Curative (C) | 2013-11-08 | 2013-11-29 | Cetuximab + Radiotherapy Load | N | Y | 300014908 | CETUXIMAB + RT |
| 300003228 | 300002252 | 1.57 | 81 | Curative (C) | 2014-01-18 | 2014-01-27 | CETUXIMAB | Y | Y | 300014917 | CETUXIMAB |
| 300003229 | 300002253 | 1.58 | 88 | Adjuvant (A) | 2013-08-15 | 2013-09-16 | Capecitabine | N | N | 300014919 | CAPECITABINE |
| 300003230 | 300002253 | 1.91 | 78 | null | 2013-08-08 | 2013-08-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300014919 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003231 | 300007388 | null | null | Curative (C) | 2014-03-16 | 2014-03-31 | Cetuximab 7 day (Cycle 1) | N | Y | 300014930 | CETUXIMAB |
| 300003233 | 300002255 | 1.52 | 44 | Curative (C) | 2015-07-30 | 2015-08-14 | Cetuximab + Radiotherapy Load | Y | Y | 300014937 | CETUXIMAB + RT |
| 300003234 | 300002256 | 1.63 | 79.1 | Neo-adjuvant (N) | 2013-09-30 | 2013-10-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300014941 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003235 | 300005890 | 1.67 | 34 | Curative (C) | 2015-01-21 | 2015-02-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300014945 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003236 | 300002257 | 1.69 | null | Adjuvant (A) | 2016-05-26 | 2016-05-26 | Capecitabine | 02 | N | 300014948 | CAPECITABINE |
| 300003237 | 300002257 | 1.67 | 54.5 | Curative (C) | 2018-12-16 | 2018-12-16 | Cetuximab 7 day (Cycle 1) | 02 | null | 300014948 | CETUXIMAB |
| 300003238 | 300002258 | 1.81 | 74.5 | Curative (C) | 2013-01-24 | 2013-02-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300014956 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003239 | 300002259 | 1.59 | null | Curative (C) | 2017-12-20 | 2017-12-20 | Cetuximab 7 day (Cycle 1) | N | N | 300014960 | CETUXIMAB |
| 300003240 | 300002260 | 1.68 | 107.3 | Adjuvant (A) | 2014-06-24 | 2014-06-24 | Capecitabine | N | N | 300014962 | CAPECITABINE |
| 300003242 | 300002262 | null | 67.15 | Adjuvant (A) | 2014-02-02 | 2014-02-21 | Capecitabine | null | N | 300014967 | CAPECITABINE |
| 300003243 | 300002263 | 1.44 | 83.8 | Adjuvant (A) | 2016-11-07 | 2016-11-23 | Capecitabine | null | N | 300014985 | CAPECITABINE |
| 300003244 | 300002263 | 1.66 | 58.9 | Palliative (P) | 2016-06-23 | 2016-07-05 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300014985 | CARBOPLATIN + PACLITAXEL |
| 300003245 | 300002264 | 1.63 | 58.2 | Palliative (P) | 2016-07-01 | 2016-07-02 | Trial Unspecified | null | N | 300014993 | TRIAL |